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Chinese hamster ovary (CHO) cells are the most commonly used host cell line for the production
of recombinant biopharmaceuticals. These biopharmaceuticals are typically secreted from CHO
cells and purified from harvested cell culture media. The purpose of this study was to investigate
changes in the secreted proteome of CHO cells over the various stages of the growth cycle
using Surface Enhanced Laser desorption ionization time-of-flight mass spectrometry (SELDI-
TOF MS). Conditioned media samples were collected each day over a 6 day growth period
from CHO-K1 cells grown in low serum (0.5% FBS) conditions in monolayer culture. Samples
were profiled on a number of ProteinChip arrays with different chromatographic surfaces. From
this study, 24 proteins were found to be differentially regulated at different phases of the growth
cycle in CHO-K1 cells, when profiled on two chromatographic surfaces, Q10 (anionic) and
IMAC30 (metal affinity) ProteinChip arrays.
Introduction
Chinese hamster ovary cells are the most commonly used
host cell line for the production of protein therapeutics. The
application of global expression profiling methods such as
proteomic analysis to mammalian cell culture processes is an
important new tool for process and cell line development (1).
Protein profiles generated from both intracellular and extracel-
lular samples from bioreactors may give insights for genetic
intervention to possibly create better host cell lines, or even to
provide clues to more rational strategies for process development
(e.g., media design). For these reasons, secreted host cell proteins
potentially contain a rich source of information that may be
exploited to improve process performance.
Depending on the nature of the product and culture process,
crude recombinant proteins are typically harvested in the late
exponential or the early stationary phase of growth and are
subjected to a multistep purification process to purify the
recombinant product from the culture medium, which also
contains contaminants such as host cell proteins and nucleic
acids (2). During the developmental process, removal of CHO
cell-derived proteins from the recombinant product is monitored
using multiproduct immunoassays. Such immunoassays are
developed by raising antibodies to a single CHO protein
preparation, usually from nonproducing CHO cell lines (3, 4).
Most of the proteomic studies to date have concentrated on
profiling cell lysates from high-producing CHO and other
producer cell lines such as NS0 to gain an understanding of the
biology of these cells to improve productivity (5-9). Few
studies to date, however, have explored the proteome of
extracellularly secreted proteins from mammalian cell lines.
Surface-enhanced laser desorption ionization time-of-flight mass
spectrometry (SELDI-TOF MS) is a high-throughput proteomic
method that uses chromatographic surfaces (e.g., cation/anion
exchange, metal affinity, hydrophobic) to retain proteins on
ProteinChip arrays based on their physicochemical character-
istics. Retained proteins and peptides are then analyzed using a
ProteinChip Reader to record the time-of-flight and calculate
the accurate molecular weight of proteins/peptides in the form
of a spectral map containing mass-to-charge ratios (m/z) and
intensities corresponding to each bound proteins/peptides.
Biomarker wizard software analyzes the spectral map and detects
differentially expressed protein/peptides with statistical signifi-
cance. This technique is ideal for the analysis of small sample
volumes and allows screening of low molecular weight proteins
that are often difficult to separate on 2D gels (<20 kDa), and
as such has been applied to profile biological fluids such as
serum for biomarker discovery (review 10). The technique has
been successfully used to demonstrate that protein profiles are
useful for the early detection of breast, prostate, and bladder
cancers (11-13). The use of SELDI-TOF MS in mammalian
cell culture processes has the potential to assess markers from
very small cell-free samples, causing minimal perturbation of
the fermentation process.
In this study, conditioned media samples from CHO-K1 cells
cultured in low serum-containing medium (0.5% FBS) were
investigated over time, representing the different phases of the
growth cycle, i.e., lag, log, and stationary phase, using SELDI-
TOF MS to monitor the differential expression of secreted host
cell proteins. Proteins and peptides that can modulate cell growth
in culture including endogenous growth factors and waste
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products are also known to be excreted by the cells, therefore
representing a valuable resource for use in potentially designing
better culture processes and media. This technique may also be
a useful way of monitoring the performance of a culture in a
reproducible manner.
Materials and Methods
Chemicals. All culture media, serum, and chemicals used in
the maintenance of the cell lines were obtained from Sigma
Aldrich (Dublin, Ireland). IMAC30, CM10, H50, Q10 Protein-
Chip arrays, all-in-one protein standard, and sinapinic acid were
obtained from Ciphergen Biosystems (CA) and Bio-Rad (Alpha
Technologies, Dublin, Ireland).
Cell Culture. The CHO-K1 cell line was obtained from the
American Type Culture Collection (ATCC). Cells were routinely
maintained at 37 °C using DMEM/Ham’s F-12 (1:1) medium
supplemented with 2 mM L-glutamine (Invitrogen), sodium
pyruvate (Invitrogen), and 10% fetal bovine serum (Sigma). For
adaptation of cells to low-serum conditions, cells were seeded
at 3  105 cells/mL in three T-75 cm2 culture flasks in 10 mL
of medium and counts were performed every second and fourth
day of culture. If cells achieved g1  106 cells/mL within 4
days of culture, they were transferred to culture medium with
a reduced serum level. (The process involved adapting cells from
10% to 5% to 2.5% to 1% and then 0.5% FBS over time.) If
not, the medium was replaced in the third flask and once cells
become confluent, they were seeded again as stated above. The
same workflow was followed until the cells were adapted to
grow in 0.5% serum-supplemented medium. Adapted cells were
seeded at 3  105 cells/mL in T-75 cm2 culture flasks with 10
mL working volume of media and were grown for 6 days at
37 °C. Control flasks containing cell-free culture media were
also processed in parallel at each time point. Cell counts were
carried out every 24 h using the trypan blue exclusion method
to assess viability. Conditioned media samples from four
biological replicates were collected, centrifuged at 170g for 15
min to remove cellular debris, decanted into clean tubes, and
stored at -80 °C until analysis.
Surface-Enhanced Laser Desorption/Ionization Time-of-
Flight Mass Spectrometry (SELDI-TOF MS) of Conditioned
Media from CHO-K1 Cells. Conditioned media samples were
concentrated using 5000 MW cutoff centricons (Millipore). Prior
to full profiling analysis, optimization studies were performed
with the day 4 sample using 10 íg and 50 íg of extracted protein
from conditioned media samples on four different chromato-
graphic surfaces to see which protein concentration and Pro-
teinChip array gave optimal results. The following ProteinChip
arrays were selected, an IMAC30 (immobilized metal affinity
capture) activated with copper ions, CM10 (weak cation-
exchange) with 20 mM Tris pH 4.5, Q10 (strong anion-
exchange) with 50 mM Tris pH 8.0, and H50 (reversed-phase
hydrophobic surface) with 10% acetonitrile/0.1% trifluoroacetic
acid. The IMAC30 and Q10 ProteinChip 8-spot arrays provided
better profiles under these conditions in terms of number and
resolution of peaks and therefore were selected for the final
profiling studies. IMAC30 arrays were coated with 5 íL of 100
mM CuSO4 for a total of 30 min (2  15 min applications) and
then rinsed with high-performance liquid chromatography
(HPLC) grade water. The copper ions were charged by applying
50 íL of 100 mM sodium acetate for 5 min. Each array was
placed in a Bioprocessor (Ciphergen) and the IMAC-Cu2+ arrays
were washed twice with 250 íL of 250 mM sodium chloride
containing 0.1% Triton X-100, and Q10 arrays were washed
twice with 50 mM Tris pH 8.0. Ten micrograms of protein from
each sample was diluted in binding buffers. Next, 250 íL of
diluted samples was applied to the spots of the arrays. The arrays
were placed on a shaker and gently agitated for 90 min to allow
for interaction of proteins with the array surface. After the
samples were removed, the IMAC-Cu2+ arrays were washed
twice with 250 íL of 250 mM sodium chloride containing 0.1%
Triton X-100, and Q10 arrays with 50 mM Tris pH 8.0 for 5
min, followed by a brief HPLC-grade water wash. Aliquots (0.8
íL) of saturated sinapinic acid (SPA; dissolved in 50%
acetonitrile containing 0.5% trifluoroacetic acid) were then
added to each of the spots which were then allowed to dry, and
the process was repeated. The IMAC-Cu2+ and Q10 ProteinChip
arrays were then analyzed in a Ciphergen Series PBS-IIC
ProteinChip System, and time-of-flight (TOF) data were gener-
ated by averaging a total of 220 laser shots collected at a
laser intensity of 200, a detector sensitivity of 8, and molecular
mass range from 5 to 20 000 Da for the low molecular weight
range and 20 000 to 100 000 Da for the high molecular weight
range.
Analysis of SELDI-TOF MS Spectra. Molecular weights
were calibrated externally using an all-in-one protein standard.
All data was analyzed using Biomarker Wizards Software,
version 3.1 (Ciphergen Biosystems). After automatic baseline
noise correction, all of the spectra were normalized together by
the ‘‘total ion content’’ method as described by the manufac-
turer, i.e., with an m/z between 5 000 and 100 000. The peaks
with an m/z value <5 000 were excluded, as these peaks were
mainly ion noise from the matrix (sinapinic acid), and 5 kDa
Figure 1. Growth profiles of CHO-K1 cells adapted to growth in low serum (0.5%) medium in monolayer culture: (A) viable cell counts and (B)
percentage viability percentage. Error bars represent the standard deviation calculated from data obtained from the experiment (n ) 4).
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cutoff centricons were used to concentrate the samples in this
analysis. Peak clusters were generated by automatically detecting
qualified mass peaks with a signal-to-noise ratio (S/N) >5 in
the first pass, completed with a second-pass peak selection of
S/N >3, with a 0.3% mass error for 5 000-20 000 Da, and the
same for 20 000-100 000 Da. Statistically significant peaks
were considered to be those with p <0.05.
Results and Discussion
Growth of CHO-K1 Cells in Low Serum Medium. CHO-
K1 cells were grown in reduced serum medium (0.5% FBS)
over 6 days of culture. Four biological replicate flasks were set
up for each time point. Cells were counted and conditioned
media samples were collected from each flask every 24 h.
Control flasks containing cell-free media were also set up at
each time point to account for serum proteins that may be
degraded to peptides over time in culture media. A 0.5% serum
background is suitable for SELDI-TOF MS profiling studies.
Figure 1 shows the growth of the cells over 6 days in culture,
clearly showing the different stages of growth (lag, logarithmic,
and stationary phases).
Reproducibility of SELDI-TOF MS for Profiling of
Conditioned Media from CHO-K1 Cells. Three biological
replicate samples of conditioned media representing lag, log,
and stationary phases of culture were profiled, along with a
technical duplicate of each sample, to assess the reproducibility
of SELDI-TOF MS for profiling conditioned media samples
from CHO-K1 cells. One time point was selected from each of
the growth phases: day 1 from the lag phase, day 3 from the
logarithmic phase, and day 5 from the stationary phase of
growth. Figure 2A shows the SELDI-TOF MS profiles for each
of these six samples at the three selected time points from
different phases of the growth cycle. Figure 2B shows the
increased expression of two peaks: one at m/z 11 347 (an 11.3
kDa protein) on the Q10 array and a second peak at m/z 14 735
(a 14.7 kDa protein) on the IMAC30 array. From this experi-
ment, coefficients of variance (CV) values were calculated from
the intensity readings from five randomly selected peaks from
each conditioned media sample from each of the ProteinChip
array surfaces. The CV values ranged from 11.42% to 20.7%
for the Q10 array, and from 8.05% to 17.4% on the IMAC30
array, demonstrating the reproducibility of the technique. We
also looked at interexperimental variability, and found that the
average mean CV from the intensity readings from five
randomly selected peaks across all experiments in the study was
22.68%. Recently SELDI-TOF MS-based serum profiling has
been subject to criticism, with results published by some groups
not being reproduced by others (14-16). However, the same
level of criticism may not apply to cell culture-based analyses
since multiple biological replicate samples from the same cell
line are easily obtainable.
Expression Difference Matching Analysis of CHO-K1
Conditioned Media Over Time in Culture. Three biological
replicate samples from each time point were profiled on each
of the two surfaces, IMAC30 and Q10 ProteinChip arrays.
Twenty four proteins/peptides were found to be differentially
Figure 2. SELDI-TOF MS profiling of day 1 (from lag phase), day 3 (from log phase), and day 5 (from stationary phase) conditioned media
from CHO-K1 cells. (A) Three biological replicate samples from each time point were profiled, along with a technical duplicate from each
sample (total of 6 samples per time point) to demonstrate the reproducibility of the method for profiling conditioned media from CHO-K1 cells.
(B) Graph showing the comparison of the average peak intensities for the 11.3 kDa protein on the Q10 array and the 14.7 kDa protein on the
IMAC30 array.
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expressed over the 6 days in culture with a p value <0.05. The
results for these 24 peaks are shown in Table 1. Figure 3A shows
the SELDI-TOF MS profiles from two of these differentially
expressed peaks at m/z 8 118 and 14 735 from the IMAC30
chip. Figure 3B clearly shows that the 8.1 kDa protein (m/z
8 118 peak) is increased until day 4 of culture and then its
expression is decreased over the next 3 days suggesting it is
being consumed by the cells or being degraded over the latter
stages of culture, possibly by proteolysis. The 14.7 kDa protein
(m/z 14 735 peak) is accumulated over time in culture, appearing
during the stationary phase, at days 5 and 6 of growth. Figure
4A shows the SELDI-TOF MS profile of two differentially
expressed peaks from the Q10 array at m/z 7 346 and 11 347.
Figure 4B clearly shows that the 7.3 kDa protein (m/z 7 346
peak) is increased over time in culture from day 1 to day 6,
and that the 11.3 kDa protein (m/z 11 347 peak) is again
increasing over time in culture but accumulating from day 4
onward.
The majority of the proteins differentially expressed on the
two chromatographic surfaces used in this study are increased
over time in culture and are therefore most likely associated
with increasing numbers of cells within the cultures, such as
the 7.3 and 11.3 kDa proteins detected on the Q10 array (Figure
4). These proteins are accumulating in the media over time and
are potential contaminants that may need to be purified from
the recombinant protein being produced by the cells. Knowledge
of these proteins may be useful for designing strategies for
monitoring and removing host cell proteins from the recombi-
nant protein product (17).
However, there are also a number of differentially expressed
proteins that show a different type of profile that may not
necessarily be due to increased expression over time in culture
as a direct result of increasing cell numbers. For example, some
of these proteins such as the 8.1 kDa protein differentially
expressed on the IMAC30 surface are secreted at the early stages
of culture, as demonstrated by the fact that it is absent in the
control, cell-free flasks (Figure 3). This may represent a protein
cleavage product or a secreted protein/peptide, and its expression
increased as the biomass increases over time. This 8.1 kDa
protein is then either consumed or degraded by the cell after
Table 1. Protein/Peptide Peaks Differentially Expressed over Time
in a Culture of CHO-K1 Cells on Q10 and IMAC30 ProteinChip
Arrays
Q10 IMAC30
m/z of peak p value m/z of peak p value
1 5 753.43 0.042 1 5 109.49 0.037
2 5 913.81 0.029 2 5 261.48 0.045
3 6 191.46 0.032 3 5 864.21 0.026
4 7 346.27 0.022 4 6 065.27 0.043
5 7 542.91 0.048 5 8 118.21 0.032
6 8 492.30 0.027 6 8 591.44 0.034
7 9 746.85 0.034 7 14 735.28 0.029
8 9 882.51 0.031 8 17 975.62 0.022
9 10 883.34 0.044 9 20 343.55 0.023
10 11 347.01 0.046 10 20 853.77 0.021
11 12 168.91 0.047 11 25 798.46 0.037
12 13 593.09 0.038
13 15 215.28 0.024
Figure 3. Differentially expressed proteins of CHO-K1 cells over time in culture. (A) Protein profiles on the IMAC-Cu2+ array of three biological
replicate samples from each time point. Profiles from control, cell-free flasks at each time point are also shown, i.e., one profile from each of days
1-6. The differentially expressed proteins at 8.1 and 14.7 kDa in each of the samples from day 1 to 6, including the controls at each time point,
are highlighted in red. (B) Graph of the comparison of the average peak intensities for 8.1 and 14.7 kDa protein/peptides over time in culture.
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day 4 of culture as the biomass levels increase with decreased
levels over days 5 and 6 of culture, either through consumption
as nutrients are used up or via the accumulation of proteases
over time. In manufacturing recombinant proteins, the use of
serum-free media for cell cultivation is preferred in order to
meet quality and regulatory requirements but this may increase
the exposure of the expressed product to proteolytic attacks that
can result in product heterogeneity, denaturation, and loss of
protein function. For example, an MMP pro-enzyme has been
found to be released from CHO cells during the production
phase of recombinant factor VIII, and as a result of autopro-
teolysis, a number of smaller, less specific MMPs were also
detected (18). In another study, pro-MMP9 (gelatinase B) was
identified from conditioned media of CHO-K1 cells grown in
serum-free conditions (19). These studies and others (20)
demonstrate that knowledge of proteolytic enzymes secreted by
CHO cells is important for optimal bioprocess conditions.
This study has also demonstrated that SELDI-TOF MS can
identify proteins that are secreted into the media and specifically
detected during the latter stages of culture, such as the profile
observed for the 14.7 kDa protein on the IMAC30 chip (Figure
3). In this case, the 14.7 kDa protein is first detected at day 5
and then increased on day 6, with no corresponding increase in
cell numbers (Figure 1A). Over the same period, however, the
cellular viability is beginning to decline (Figure 1B). The 14.7
kDa protein might be linked to cell death and are therefore
released by the cells as the viability begins to decrease, as waste
products begin to accumulate in the media. This knowledge may
be useful in designing cell-engineering strategies using anti-
apoptotic mechanisms to increase viability over time, especially
for suspension cultures which are subjected to harsher conditions
compared to cells grown in monolayer (21).
The next steps are to identify these 24 proteins/peptides using
various enrichment techniques followed by mass spectrometry,
and also to apply the technique to more bioprocess-relevant
conditions such as serum-free suspension culture. Identification
of protein markers by SELDI TOF MS remains challenging due
to the fact that it is difficult to elute proteins/peptides of interest
from ProteinChip arrays for direct mass spectrometry identifica-
tion, as compared to 2D gel-based methods. Identification can
involve fractionation and enrichment of proteins/peptides of
interest using spin columns with the same chemistry as the
ProteinChip array surfaces, followed by separation on 1D gels
and identification by mass spectrometry (22, 23). However,
despite these challenges, the use of SELDI-TOF MS to monitor
culture progress for process optimization is attractive because
of the small sample size and the rapid assay time, compared to
other possible monitoring methods. Proteomic patterns (or
protein “fingerprints”) may also be very useful for distinguishing
or predicting a “good” or “bad” culture with high sensitivity
and specificity, and this approach is being used in discovering
protein profiles that distinguish disease and disease-free states
(24).
Figure 4. Differentially expressed proteins of CHO-K1 cells over time in culture. (A) Protein profiles on Q10 array of three biological replicate
samples from each time point. Profiles from control, cell-free flasks at each time point are also shown, i.e., one profile from each of days 1-6. The
differentially expressed proteins at 7.3 and 11.3 kDa in each of the samples from day 1 to 6, including the controls at each time point, are highlighted
in red. (B) Graph showing the comparison of the average peak intensities for 7.3 and 11.3 kDa protein/peptides over time in culture.
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Conclusions
This proof of concept study to evaluate the potential use of
SELDI TOF MS to discover process-related markers has yielded
24 differentially expressed proteins over time in the culture of
CHO-K1 cells grown in monolayer in the low molecular weight
range, <20 kDa. These proteins/peptides appear to have a
number of distinct profiles over the course of the culture. These
results suggest that secreted host cell proteins potentially contain
a rich source of information that may be exploited to improve
process performance, and a greater understanding of these
secreted proteins is required in order to potentially achieve these
aims.
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